Translational Development Acquisition Stock Performance
| TDAC Stock | USD 10.56 0.06 0.57% |
Translational Development has a performance score of 13 on a scale of 0 to 100. The entity has a beta of -0.0011, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Translational Development are expected to decrease at a much lower rate. During the bear market, Translational Development is likely to outperform the market. Translational Development right now has a risk of 0.12%. Please validate Translational Development sortino ratio, potential upside, and the relationship between the jensen alpha and maximum drawdown , to decide if Translational Development will be following its existing price patterns.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Translational Development Acquisition are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Translational Development is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 2021.00 | |
| Total Cashflows From Investing Activities | -174.2 M |
Translational | Build AI portfolio with Translational Stock |
Translational Development Relative Risk vs. Return Landscape
If you would invest 1,043 in Translational Development Acquisition on October 26, 2025 and sell it today you would earn a total of 13.00 from holding Translational Development Acquisition or generate 1.25% return on investment over 90 days. Translational Development Acquisition is currently generating 0.02% in daily expected returns and assumes 0.1188% risk (volatility on return distribution) over the 90 days horizon. In different words, 1% of stocks are less volatile than Translational, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Translational Development Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Translational Development's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Translational Development Acquisition, and traders can use it to determine the average amount a Translational Development's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Based on monthly moving average Translational Development is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Translational Development by adding it to a well-diversified portfolio.
Translational Development Fundamentals Growth
Translational Stock prices reflect investors' perceptions of the future prospects and financial health of Translational Development, and Translational Development fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Translational Stock performance.
| Return On Asset | -0.0064 | ||||
| Current Valuation | 231.4 M | ||||
| Shares Outstanding | 17.25 M | ||||
| Price To Book | 1.33 X | ||||
| EBITDA | (71.01 K) | ||||
| Cash And Equivalents | 972.79 K | ||||
| Cash Per Share | 0.13 X | ||||
| Total Debt | 6.11 T | ||||
| Debt To Equity | 1.01 % | ||||
| Book Value Per Share | (0.29) X | ||||
| Cash Flow From Operations | (851.45 K) | ||||
| Earnings Per Share | 0.22 X | ||||
| Total Asset | 175 M | ||||
| Retained Earnings | (5.6 M) | ||||
About Translational Development Performance
By analyzing Translational Development's fundamental ratios, stakeholders can gain valuable insights into Translational Development's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Translational Development has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Translational Development has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Trident Acquisitions Corp. does not have significant operations. Trident Acquisitions Corp. was incorporated in 2016 and is headquartered in New York, New York. Trident Acquisitions operates under Shell Companies classification in the United States and is traded on NASDAQ Exchange.Things to note about Translational Development performance evaluation
Checking the ongoing alerts about Translational Development for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Translational Development help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Translational Development has high likelihood to experience some financial distress in the next 2 years | |
| Translational Development Acquisition currently holds 6.11 T in liabilities with Debt to Equity (D/E) ratio of 1.01, which is about average as compared to similar companies. Translational Development has a current ratio of 0.19, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Translational Development's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (71.01 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Translational Development Acquisition currently holds about 972.79 K in cash with (851.45 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13. | |
| Translational Development has a frail financial position based on the latest SEC disclosures | |
| Over 94.0% of Translational Development shares are owned by institutional investors |
- Analyzing Translational Development's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Translational Development's stock is overvalued or undervalued compared to its peers.
- Examining Translational Development's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Translational Development's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Translational Development's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Translational Development's stock. These opinions can provide insight into Translational Development's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Translational Stock analysis
When running Translational Development's price analysis, check to measure Translational Development's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Translational Development is operating at the current time. Most of Translational Development's value examination focuses on studying past and present price action to predict the probability of Translational Development's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Translational Development's price. Additionally, you may evaluate how the addition of Translational Development to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |